369 related articles for article (PubMed ID: 29606096)
1. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
2. Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention.
Uzor S; Zorzou P; Bowler E; Porazinski S; Wilson I; Ladomery M
Gene; 2018 Sep; 670():46-54. PubMed ID: 29802995
[TBL] [Abstract][Full Text] [Related]
3. CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer.
Uzor S; Porazinski SR; Li L; Clark B; Ajiro M; Iida K; Hagiwara M; Alqasem AA; Perks CM; Wilson ID; Oltean S; Ladomery MR
Sci Rep; 2021 Apr; 11(1):7963. PubMed ID: 33846420
[TBL] [Abstract][Full Text] [Related]
4. Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia.
Jakubauskiene E; Vilys L; Makino Y; Poellinger L; Kanopka A
J Biol Chem; 2015 Jul; 290(29):18079-18089. PubMed ID: 26023237
[TBL] [Abstract][Full Text] [Related]
5. RNA splicing and splicing regulator changes in prostate cancer pathology.
Munkley J; Livermore K; Rajan P; Elliott DJ
Hum Genet; 2017 Sep; 136(9):1143-1154. PubMed ID: 28382513
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of alternative splicing by a newly developed inhibitor of Clks.
Muraki M; Ohkawara B; Hosoya T; Onogi H; Koizumi J; Koizumi T; Sumi K; Yomoda J; Murray MV; Kimura H; Furuichi K; Shibuya H; Krainer AR; Suzuki M; Hagiwara M
J Biol Chem; 2004 Jun; 279(23):24246-54. PubMed ID: 15010457
[TBL] [Abstract][Full Text] [Related]
7. Clk/STY (cdc2-like kinase 1) and Akt regulate alternative splicing and adipogenesis in 3T3-L1 pre-adipocytes.
Li P; Carter G; Romero J; Gower KM; Watson J; Patel NA; Cooper DR
PLoS One; 2013; 8(1):e53268. PubMed ID: 23308182
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion.
Liu Y; Conaway L; Rutherford Bethard J; Al-Ayoubi AM; Thompson Bradley A; Zheng H; Weed SA; Eblen ST
Nucleic Acids Res; 2013 May; 41(9):4949-62. PubMed ID: 23519612
[TBL] [Abstract][Full Text] [Related]
9. CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
Funnell T; Tasaki S; Oloumi A; Araki S; Kong E; Yap D; Nakayama Y; Hughes CS; Cheng SG; Tozaki H; Iwatani M; Sasaki S; Ohashi T; Miyazaki T; Morishita N; Morishita D; Ogasawara-Shimizu M; Ohori M; Nakao S; Karashima M; Sano M; Murai A; Nomura T; Uchiyama N; Kawamoto T; Hara R; Nakanishi O; Shumansky K; Rosner J; Wan A; McKinney S; Morin GB; Nakanishi A; Shah S; Toyoshiba H; Aparicio S
Nat Commun; 2017 Feb; 8(1):7. PubMed ID: 28232751
[TBL] [Abstract][Full Text] [Related]
10. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
[TBL] [Abstract][Full Text] [Related]
11. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
Jain P; Karthikeyan C; Moorthy NS; Waiker DK; Jain AK; Trivedi P
Curr Drug Targets; 2014 May; 15(5):539-50. PubMed ID: 24568585
[TBL] [Abstract][Full Text] [Related]
12. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase clk/STY is differentially regulated during erythroleukemia cell differentiation: a bias toward the skipped splice variant characterizes postcommitment stages.
García-Sacristán A; Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
Cell Res; 2005 Jul; 15(7):495-503. PubMed ID: 16045812
[TBL] [Abstract][Full Text] [Related]
14. Combination of Clk family kinase and SRp75 modulates alternative splicing of Adenovirus E1A.
Yomoda J; Muraki M; Kataoka N; Hosoya T; Suzuki M; Hagiwara M; Kimura H
Genes Cells; 2008 Mar; 13(3):233-44. PubMed ID: 18298798
[TBL] [Abstract][Full Text] [Related]
15. WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1.
Belali T; Wodi C; Clark B; Cheung MK; Craig TJ; Wheway G; Wagner N; Wagner KD; Roberts S; Porazinski S; Ladomery M
Biochim Biophys Acta Gene Regul Mech; 2020 Dec; 1863(12):194642. PubMed ID: 33017668
[TBL] [Abstract][Full Text] [Related]
16. A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene.
An J; Nakajima T; Shibata H; Arimura T; Yasunami M; Kimura A
J Autoimmun; 2013 Dec; 47():25-33. PubMed ID: 23953137
[TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.
Duncan PI; Stojdl DF; Marius RM; Bell JC
Mol Cell Biol; 1997 Oct; 17(10):5996-6001. PubMed ID: 9315658
[TBL] [Abstract][Full Text] [Related]
18. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.
Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL
PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203
[TBL] [Abstract][Full Text] [Related]
19. Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer.
Babu N; Pinto SM; Biswas M; Subbannayya T; Rajappa M; Mohan SV; Advani J; Rajagopalan P; Sathe G; Syed N; Radhakrishna VD; Muthusamy O; Navani S; Kumar RV; Gopisetty G; Rajkumar T; Radhakrishnan P; Thiyagarajan S; Pandey A; Gowda H; Majumder P; Chatterjee A
Gastric Cancer; 2020 Sep; 23(5):796-810. PubMed ID: 32333232
[TBL] [Abstract][Full Text] [Related]
20. Regulation of influenza A virus mRNA splicing by CLK1.
Artarini A; Meyer M; Shin YJ; Huber K; Hilz N; Bracher F; Eros D; Orfi L; Keri G; Goedert S; Neuenschwander M; von Kries J; Domovich-Eisenberg Y; Dekel N; Szabadkai I; Lebendiker M; Horváth Z; Danieli T; Livnah O; Moncorgé O; Frise R; Barclay W; Meyer TF; Karlas A
Antiviral Res; 2019 Aug; 168():187-196. PubMed ID: 31176694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
